Radiologic progression of glioblastoma under therapy: an exploratory analysis of AVAglio
Abstract: Background. In this exploratory analysis of AVAglio, a randomized phase III clinical study that investigated the addition of bevacizumab (Bev) to radiotherapy/temozolomide in newly diagnosed glioblastoma, we aim to radiologically characterize glioblastoma on therapy until progression and i...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
Neuro-Oncology
Year: 2017, Volume: 20, Issue: 4, Pages: 557-566 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nox162 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/neuonc/nox162 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/20/4/557/4102288 |
| Author Notes: | Martha Nowosielski, Benjamin M. Ellingson, Olivier L. Chinot, Josep Garcia, Cedric Revil, Alexander Radbruch, Ryo Nishikawa, Warren P. Mason, Roger Henriksson, Frank Saran, Philipp Kickingereder, Michael Platten, Thomas Sandmann, Lauren E. Abrey, Timothy F. Cloughesy, Martin Bendszus, and Wolfgang Wick |
| Summary: | Abstract: Background. In this exploratory analysis of AVAglio, a randomized phase III clinical study that investigated the addition of bevacizumab (Bev) to radiotherapy/temozolomide in newly diagnosed glioblastoma, we aim to radiologically characterize glioblastoma on therapy until progression and investigate whether the type of radiologic progression differs between treatment arms and is related to survival and molecular data |
|---|---|
| Item Description: | Published: 01 September 2017 Gesehen am 26.02.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nox162 |